No Data
No Data
Tonix Pharmaceuticals Presents Data, Analyses of TNX-102 SL Effects
First Mpox Case Linked to African Outbreak Reported in U.S.
Tonix Pharmaceuticals Publishes Peer-Reviewed Publication In MSphere Journal Highlighting Tolerability Of Its Single-Dose Mpox And Smallpox Vaccine Candidate TNX-801, In Immune-Compromised Animals
Express News | Tonix Pharmaceuticals Announces Peer-Reviewed Publication in Msphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate Tnx-801, in Immune-Compromised Animals
Tonix Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Tonix Pharmaceuticals Reports Q3 EPS (23c), Consensus ($2.93)
No Data
No Data